Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The price of Trevi Therapeutics Inc (NASDAQ: TRVI) closed at $4.32 in the last session, down -5.88% from day before closing price of $4.59. In other words, the price has decreased by -$5.88 from its previous closing price. On the day, 0.54 million shares were traded. TRVI stock price reached its highest trading level at $4.68 during the session, while it also had its lowest trading level at $4.315.
Ratios:
We take a closer look at TRVI’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 7.38 and its Current Ratio is at 7.38. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 12, 2024, Reiterated its Buy rating but revised its target price to $7.50 from $6 previously.
On August 30, 2024, Raymond James started tracking the stock assigning a Outperform rating and target price of $9.Raymond James initiated its Outperform rating on August 30, 2024, with a $9 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 06 ’24 when GOOD JENNIFER L sold 4,219 shares for $3.03 per share. The transaction valued at 12,784 led to the insider holds 213,313 shares of the business.
GOOD JENNIFER L sold 1,840 shares of TRVI for $5,587 on Sep 09 ’24. The President & CEO now owns 213,313 shares after completing the transaction at $3.04 per share. On Sep 05 ’24, another insider, GOOD JENNIFER L, who serves as the President & CEO of the company, sold 40,277 shares for $3.11 each. As a result, the insider received 125,310 and left with 213,313 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TRVI now has a Market Capitalization of 386059808 and an Enterprise Value of 267679872.
Stock Price History:
Over the past 52 weeks, TRVI has reached a high of $4.68, while it has fallen to a 52-week low of $1.27. The 50-Day Moving Average of the stock is 30.86%, while the 200-Day Moving Average is calculated to be 42.97%.
Shares Statistics:
According to the various share statistics, TRVI traded on average about 1.71M shares per day over the past 3-months and 776550 shares per day over the past 10 days. A total of 75.45M shares are outstanding, with a floating share count of 52.99M. Insiders hold about 40.71% of the company’s shares, while institutions hold 35.35% stake in the company. Shares short for TRVI as of 1734048000 were 4656062 with a Short Ratio of 2.72, compared to 1731628800 on 1752876. Therefore, it implies a Short% of Shares Outstanding of 4656062 and a Short% of Float of 9.4.
